133 related articles for article (PubMed ID: 21095465)
1. Catechol-O-methyltransferase and pain.
Kambur O; Männistö PT
Int Rev Neurobiol; 2010; 95():227-79. PubMed ID: 21095465
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis.
Tammimäki A; Männistö PT
Pharmacogenet Genomics; 2012 Sep; 22(9):673-91. PubMed ID: 22722321
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
[TBL] [Abstract][Full Text] [Related]
4. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
5. Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene.
Martínez-Jauand M; Sitges C; Rodríguez V; Picornell A; Ramon M; Buskila D; Montoya P
Eur J Pain; 2013 Jan; 17(1):16-27. PubMed ID: 22528689
[TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis.
van Esch AA; de Vries E; Te Morsche RH; van Oijen MG; Jansen JB; Drenth JP
Neth J Med; 2011; 69(7):330-4. PubMed ID: 21934178
[TBL] [Abstract][Full Text] [Related]
8. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population.
Armero P; Muriel C; Santos J; Sànchez-Montero FJ; Rodríguez RE; González-Sarmiento R
Eur J Pain; 2005 Jun; 9(3):229-32. PubMed ID: 15862471
[TBL] [Abstract][Full Text] [Related]
9. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
Rakvåg TT; Klepstad P; Baar C; Kvam TM; Dale O; Kaasa S; Krokan HE; Skorpen F
Pain; 2005 Jul; 116(1-2):73-8. PubMed ID: 15927391
[TBL] [Abstract][Full Text] [Related]
10. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of catechol-O-methyltransferase sensitize mice to pain.
Kambur O; Talka R; Ansah OB; Kontinen VK; Pertovaara A; Kalso E; Männistö PT
Br J Pharmacol; 2010 Dec; 161(7):1553-65. PubMed ID: 20726980
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis for individual variations in pain perception and the development of a chronic pain condition.
Diatchenko L; Slade GD; Nackley AG; Bhalang K; Sigurdsson A; Belfer I; Goldman D; Xu K; Shabalina SA; Shagin D; Max MB; Makarov SS; Maixner W
Hum Mol Genet; 2005 Jan; 14(1):135-43. PubMed ID: 15537663
[TBL] [Abstract][Full Text] [Related]
13. Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties.
Pertovaara A; Wei H; Kalmari J; Ruotsalainen M
Exp Neurol; 2001 Feb; 167(2):425-34. PubMed ID: 11161631
[TBL] [Abstract][Full Text] [Related]
14. Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1.
Walsh J; Tighe O; Lai D; Harvey R; Karayiorgou M; Gogos JA; Waddington JL; O'Tuathaigh CM
Brain Res; 2010 Aug; 1348():114-9. PubMed ID: 20561508
[TBL] [Abstract][Full Text] [Related]
15. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
16. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.
Salih SM; Jamaluddin M; Salama SA; Fadl AA; Nagamani M; Al-Hendy A
Fertil Steril; 2008 May; 89(5 Suppl):1414-21. PubMed ID: 17612537
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
[TBL] [Abstract][Full Text] [Related]
18. Variation in the COMT gene: implications for pain perception and pain treatment.
Andersen S; Skorpen F
Pharmacogenomics; 2009 Apr; 10(4):669-84. PubMed ID: 19374521
[TBL] [Abstract][Full Text] [Related]
19. Haplotypes of catechol-O-methyltransferase modulate intelligence-related brain white matter integrity.
Liu B; Li J; Yu C; Li Y; Liu Y; Song M; Fan M; Li K; Jiang T
Neuroimage; 2010 Mar; 50(1):243-9. PubMed ID: 20005296
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two new variants of human catechol O-methyltransferase in vitro.
Li Y; Yang X; van Breemen RB; Bolton JL
Cancer Lett; 2005 Dec; 230(1):81-9. PubMed ID: 16253764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
